Skip to main content
Home
  • Forum
  • Join Now
  • Rejoin
  • Cart
  • My Account
  • Logout

Main navigation

  • Membership
    • Membership Benefits
    • Join PALTmed
    • Renew My Membership
    • Chapters
    • Get Involved
    • Leadership Program
    • Fellowship Program
    • PALTC Benefits Program
  • Education
    • Event Calendar
    • Annual Meeting
    • Business of Medicine Symposium
    • Care Continuum 26
    • Core Curriculum on Medical Direction
    • PALTlearn (online ed)
    • Podcasts
    • Futures Program
    • CME & MOC
  • Professional Pathways
    • Medical Direction
    • Certification (CMD)
    • Fellowship Program
    • Practice Management
    • Care Settings
    • Career Center
  • Resources
    • ACOs
    • Billing & Coding
    • Clinical Topic Search
    • Clinical Practice Guidelines
    • Product Store
    • Industry Dialogues
  • Advocacy
    • Advocacy Summit
    • Priorities & Resources
    • PALTmed Policy Finder
    • Current Issues
    • Action Center
    • Grassroots Advocacy
  • Publications
    • JAMDA
    • Caring for the Ages
    • PALTnews Briefs
    • Latest News
  • About
    • Who We Are
    • Governance
    • House of Delegates
    • Foundation for PALTC Medicine
AMDA – The Society for Post-Acute and Long-Term Care Medicine

Industry Dialogues

Treating Severe Hypoglycemia in Adults with T1D and T2D

Sponsor: Xeris Pharmaceuticals, Inc.

Breadcrumb

Home  /   Industry Dialogues  /   Xeris

Please see the Full Prescribing Information.

Xeris - LLTC Brochure Image
Xeris - LTC Cast Study-IL Image
Xeris LTC Case Study- RI Image
Xeris Checklist Image
Xeris HCP LTC One-Pager Image

Caring for the Ages

Prevention, Recognition, and Treatment of Diabetes-related Hypoglycemia in PALTC Residents

Xeris Caring Article Image

 

 

Caring for the Ages

New Options to Simplify the Treatment of Severe Hypoglycemia in Long-Term Care

Xeris Caring Article Image 2

These publications may contain information not addressed in the approved label for GVOKE® (glucagon) injection. Xeris Pharmaceuticals® cannot recommend the use of GVOKE® outside the FDA-approved labeling.

Questions or Feedback?

Contact:
Xeris Long-Term Care Team
LTCsupport@xerispharma.com

Gvoke | Xeris Pharmaceuticals, Inc.

Contact Us

9861 Broken Land Parkway
Suite 100
Columbia, MD 21046
410-740-9743

Contact us

Helpful Links
  • About
  • Annual Meeting
  • Policy & Advocacy
  • Membership
  • Forum
  • Career Center
  • FAQ
  • Certification
  • Foundation for PALTC Medicine
  • Corporate Partners

© 2026 All Rights Reserved. | Privacy Policy